In a cohort of NSCLC patients with neoadjuvant platinum-based chemotherapy, Kim et al. reported that the African American had significantly reduced SLC31A1 expression in tumor, lowered tissue platinum concentration and decreased tumor shrinkage as compared to Caucasians 6. The gene discussed is SLC31A1; the disease is non-small cell lung carcinoma.